Department of Internal Medicine, National Cheng Kung University Hospital and College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan.
Sci Rep. 2023 May 16;13(1):7922. doi: 10.1038/s41598-023-34889-z.
Few literatures discussed the relationship of glycemic control and body mass index (BMI) with the risk of pyogenic liver abscess. We conducted a population-based cohort study using participants of a community-based health screening program in Taiwan from 2005 to 2008 (n = 125,865). Information on fasting plasma glucose (FPG), BMI, and other potential risk factors of liver abscess were collected at baseline. Incidence of pyogenic liver abscess was ascertained using inpatient records from the National Health Insurance database. During a median 8.6 years of followed up, 192 incident cases of pyogenic liver abscess were reported. The incidence rate of pyogenic liver abscess was 70.2 and 14.7 per 100,000 in the diabetic and non-diabetic population respectively. In multivariable Cox regression analysis, the adjusted hazard ratio (HR) was 2.18 (95% confidence interval (CI) 1.22-3.90) in patients with diabetes with good glycemic control (FPG ≤ 130 mg/dl) and 3.34 (95% CI 2.37-4.72) in those with poor glycemic control (FPG > 130 mg/dl), when compared with non-diabetics. In the dose-response analysis, the risk of liver abscess increased monotonically with increasing FPG. After adjusting for diabetes and other comorbidities, overweight (25 ≤ BMI < 30) (adjusted HR: 1.43, 95% CI 1.05-1.95) and obese (BMI ≥ 30) (adjusted HR: 1.75, 95% CI 1.09-2.81) populations had a higher risk of liver abscess when compared to people with normal weight. Diabetes, especially poorly controlled disease, and high BMI were associated with higher risk of pyogenic liver abscess. Improving glycemic control and weight reduction may reduce the risk of developing pyogenic liver abscess.
关于血糖控制和体重指数(BMI)与化脓性肝脓肿风险的关系,文献报道较少。我们对 2005 年至 2008 年参加台湾社区健康筛查计划的人群进行了一项基于人群的队列研究(n=125865)。在基线时收集空腹血糖(FPG)、BMI 和其他潜在肝脓肿危险因素的信息。化脓性肝脓肿的发病情况通过国家健康保险数据库中的住院记录确定。在中位 8.6 年的随访期间,报告了 192 例化脓性肝脓肿的发病病例。糖尿病和非糖尿病患者的化脓性肝脓肿发病率分别为 70.2 和 14.7/10 万。在多变量 Cox 回归分析中,血糖控制良好(FPG≤130mg/dl)的糖尿病患者调整后的风险比(HR)为 2.18(95%置信区间(CI)1.22-3.90),血糖控制不佳(FPG>130mg/dl)的糖尿病患者调整后的 HR 为 3.34(95%CI 2.37-4.72),与非糖尿病患者相比。在剂量反应分析中,随着 FPG 的升高,肝脓肿的风险呈单调递增。在调整了糖尿病和其他合并症后,超重(25≤BMI<30)(调整后的 HR:1.43,95%CI 1.05-1.95)和肥胖(BMI≥30)(调整后的 HR:1.75,95%CI 1.09-2.81)人群患肝脓肿的风险高于体重正常人群。糖尿病,尤其是控制不佳的疾病和高 BMI,与化脓性肝脓肿风险增加相关。改善血糖控制和减轻体重可能会降低发生化脓性肝脓肿的风险。